1d
WRIC Richmond on MSNFDA approves first opioid-free painkiller in over two decadesThe U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
2hon MSN
A new report released by an anti-transnational crime group has identified the core chemical components of kush, a synthetic ...
West Virginia has the highest opioid overdose mortality rate in the country, and leaders are bringing new legislation into ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.
In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...
Palghar: The Union health ministry has stopped operations and production of Aveo Pharmaceuticals Ltd. (Aveo) following ...
4d
HealthDay on MSNOD Deaths Decline in U.S., Driven By Drop In Opioid FatalitiesAmerica’s opioid crisis is showing signs of subsiding, a new report from the U.S. Centers for Disease Control and Prev ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.
A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results